Search

everythinglearnresearchcommunity

for

Search:↓

New information shows Valproate may protect the brain and reduce breathing failure risk but can cause liver damage and other side effects, with genetics affecting dosage needs.

GLP-1 receptor agonists can help skin conditions but may cause hair loss and other skin issues.

Dutasteride potentially improves cell survival and reduces retinal damage in retinitis pigmentosa.

Topical diphencyprone effectively treated a 9-year-old boy's alopecia areata with fewer side effects.

Peficitinib can turn human fibroblasts into cells that help grow hair.

A new compound effectively inhibits human 5α-reductase 1.

Inclisiran is effective at lowering cholesterol.

Avoiding dyed wigs and clothing improved severe allergic reactions in a woman treated with diphencyprone.

Upadacitinib effectively treated severe atopic dermatitis, vitiligo, and alopecia areata in one patient.

PDRN is effective and safe for healing wounds and skin issues.

The new progesterone derivatives effectively inhibit 5α-reductase and bind to the androgen receptor.

New indole-based compounds, particularly cemtirestat, show promise as dual-function drugs for diabetic complications.

Dupilumab improved severe atopic dermatitis in a patient who didn't respond to other treatments.

Janus Kinase inhibitors are effective and have an acceptable safety profile for treating moderate to severe Ulcerative Colitis.

Danoprevir, remdesivir, and saridegib may effectively inhibit SARS-CoV-2.

The FDA approved a new breast cancer treatment, found flu shots may reduce heart risks, questioned the safety of fast-tracked drug approvals, showed statins don't help with certain pneumonia, and approved a new dementia imaging agent.

Researchers created a skin patch that delivers two drugs for treating enlarged prostate, which may improve patient use and dosage control.

The chitosan/PDRN polyplex improved wound healing in diabetic rats.

BIVV009 is a safe treatment for bullous pemphigoid that reduces C3 deposition without harmful side effects.

New JAK inhibitor drugs show promise for treating skin diseases but need more research on safety and effectiveness.

Finasteride blocks deoxycorticosterone's anticonvulsant effects in infant rats, but indomethacin doesn't.

Targeting the PGI2 pathway may help heal diabetic foot ulcers.

Baricitinib can help improve hair loss and skin color issues in people with Down syndrome.

The effect of GLP-1 RAs on erectile function is unclear and needs more research.

The committee decided not to approve the drug due to low effectiveness and high risks.

Combining DPCP with PRP doesn't improve hair regrowth in alopecia areata.

Lifestyle changes are more effective than metformin for reducing type 2 diabetes risk.

Abrocitinib may effectively treat Lichen Planopilaris.

JAK inhibitors may effectively treat lichen planopilaris and frontal fibrosing alopecia with minimal side effects.